Legal Status and Safety

Online, PT-141 is sometimes sold as a libido booster for anyone. Its real position is much narrower: an approved medicine for one diagnosis in one country, and an unlicensed research chemical everywhere else.

Medicines Regulators

• United States: Vyleesi is a prescription medicine approved only for premenopausal women with acquired, generalised hypoactive sexual desire disorder that is not caused by another illness, a relationship problem or a medicine.
• European Union: no bremelanotide medicine has a marketing authorisation. Selling it with health claims falls under medicines law.
• United Kingdom: the MHRA has not licensed any bremelanotide product.
• Other countries: rules on importing and holding research peptides differ, so the local position always needs checking.

Known Side Effects

In the trials, nausea was by far the most common problem, affecting about 40% of women. Flushing, headache, vomiting and reactions where the injection went in were also reported. A small number of women developed darker patches of skin on the face, gums or breasts, which did not always fade.

Blood Pressure

Bremelanotide causes a short-lived rise in blood pressure and a slight drop in heart rate after each use. For this reason the US label says it should not be used by people with uncontrolled high blood pressure or known heart disease. The same effect ended the nasal spray programme in 2008.

What Is Not Known

• Use outside the label: there is little data on men, on postmenopausal women or on use alongside other medicines.
• Effects on other medicines: the US label notes that it can slow down the stomach, which may change how some tablets are absorbed.
• Long-term use: the longest data cover about a year and a half, and most of that period was not placebo-controlled.
• Product quality: research-grade powders are not made to medicine standards and carry no patient leaflet.

A Laboratory Reagent

Research-grade PT-141 is sold for experiments. It comes with no approved dose, no medical supervision and no route for reporting side effects.

Bottom Line

Bremelanotide is a real medicine with a narrow approval in the US and a well-known set of side effects. It has no licence in Europe or the UK, and anyone thinking about it for health reasons should talk to a doctor first.

This page gives general information and is not legal advice.